X0407 4/A 2023-03-06 2023-03-08 0 0001642380 Oncocyte Corp OCX 0001590144 PURA VIDA INVESTMENTS, LLC 512 W 22ND STREET 7TH FLOOR NEW YORK NY 10011 0 0 1 0 0001789193 Kamen Efrem C/O PURA VIDA INVESTMENTS, LLC 512 W 22ND STREET, 7TH FLOOR NEW YORK NY 10011 0 0 1 0 0 Common Stock 2023-03-06 4 J 0 3890111 D 4589571 I By the Managed Accounts. Common Stock 767952 I By Pura Vida X Fund LP Common Stock 1381438 I By the Retirement Trust Common Stock 7427202 I By Pura Vida Master Fund, Ltd. Warrant to purchase common stock 1.53 2023-03-06 4 J 0 440964 D 2022-04-19 2027-04-19 Common Stock 440964 517245 I By the Managed Accounts. Warrant to purchase common stock 1.53 2022-04-19 2027-04-19 Common Stock 832949 832949 I By Pura Vida Master Fund, Ltd. Warrant to purchase common stock 1.53 2022-04-19 2027-04-19 Common Stock 383976 383976 I By Pura Vida X Fund LP Warrant to purchase common stock 1.53 2022-04-19 2027-04-19 Common Stock 690719 690719 I By the Retirement Trust As of March 6, 2023, the Reporting Persons no longer have voting and dispositive power for certain Managed Accounts and therefore such shares are no longer deemed beneficially owned by the Reporting Persons. Not applicable. Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed accounts (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI. By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any. As of March 6, 2023, the Reporting Persons no longer have voting and dispositive power for certain Managed Accounts and therefore the warrants and the underlying common stock are no longer deemed beneficially owned by the Reporting Persons. See footnotes 3 and 4. This amendment is being filed to include information about warrants, which was inadvertently omitted from the original Form 4. /s/ Efrem Kamen, Managing Member of Pura Vida Investments, LLC 2023-04-18 /s/ Efrem Kamen 2023-04-18